MDGL
MDGL577.300USD
-8.910-1.52%
Close 12/05, 16:00（ET）Quotes delayed by 15 min
13.11BMarket Cap
--P/E TTM
More Details of Madrigal Pharmaceuticals Inc Company
MDGL Info
Ticker SymbolMDGL
Company nameMadrigal Pharmaceuticals Inc
IPO dateFeb 06, 2007
CEOMr. Bill Sibold
Number of employees528
Security typeOrdinary Share
Fiscal year-endFeb 06
Address200 Barr Harbor Dr Ste 400
CityWEST CONSHOHOCKEN
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code19428-2978
Phone14043809263
Websitehttps://www.madrigalpharma.com/
Ticker SymbolMDGL
IPO dateFeb 06, 2007
CEOMr. Bill Sibold
Company Executives of MDGL
Name
Name/Position
Position
Shareholding
Change
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
--
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
Ms. Shannon Kelley
Ms. Shannon Kelley
Executive Vice President, Chief Legal Counsel
Executive Vice President, Chief Legal Counsel
--
-100.00%
Mr. James M. Daly
Mr. James M. Daly
Independent Director
Independent Director
--
--
Mr. Julian C. Baker
Mr. Julian C. Baker
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bill Sibold
Mr. Bill Sibold
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
--
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
9.43%
RTW Investments L.P.
8.78%
Paulson & Co. Inc.
8.40%
Janus Henderson Investors
8.11%
Avoro Capital Advisors LLC
8.07%
Other
57.21%
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
9.43%
RTW Investments L.P.
8.78%
Paulson & Co. Inc.
8.40%
Janus Henderson Investors
8.11%
Avoro Capital Advisors LLC
8.07%
Other
57.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
44.82%
Investment Advisor
31.54%
Hedge Fund
15.38%
Family Office
8.41%
Individual Investor
4.82%
Research Firm
3.21%
Corporation
2.89%
Sovereign Wealth Fund
0.78%
Pension Fund
0.67%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
657
21.99M
96.81%
-2.57M
2025Q2
650
23.67M
106.20%
-1.56M
2025Q1
668
23.83M
107.57%
-1.54M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Baker Bros. Advisors LP
2.14M
9.61%
+165.68K
+8.38%
Aug 20, 2025
RTW Investments L.P.
1.99M
8.94%
--
--
Jun 30, 2025
Paulson & Co. Inc.
2.09M
9.37%
-10.00K
-0.48%
Jun 30, 2025
Janus Henderson Investors
2.19M
9.83%
-14.10K
-0.64%
Jun 30, 2025
Avoro Capital Advisors LLC
1.88M
8.41%
-147.22K
-7.28%
Jun 30, 2025
The Vanguard Group, Inc.
1.87M
8.41%
+186.99K
+11.08%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.26M
5.63%
-59.53K
-4.53%
Jun 30, 2025
State Street Investment Management (US)
690.72K
3.1%
-67.80K
-8.94%
Jun 30, 2025
SQN, L.L.C.
655.54K
2.94%
--
--
Apr 01, 2025
Geode Capital Management, L.L.C.
414.39K
1.86%
-6.48K
-1.54%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Biotechnology & Genome ETF
3.75%
State Street SPDR S&P Biotech ETF
3.06%
Invesco Dorsey Wright Healthcare Momentum ETF
2.54%
Pinnacle Focused Opportunities ETF
2.43%
Virtus LifeSci Biotech Products ETF
2.25%
ProShares Ultra Nasdaq Biotechnology
1.62%
Goldman Sachs Future Health Care Equity ETF
1.44%
Global X Guru Index ETF
1.36%
Tema Heart & Health ETF
1.33%
Direxion Daily S&P Biotech Bull 3X Shares
1.18%
View more
Invesco Biotechnology & Genome ETF
Proportion3.75%
State Street SPDR S&P Biotech ETF
Proportion3.06%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion2.54%
Pinnacle Focused Opportunities ETF
Proportion2.43%
Virtus LifeSci Biotech Products ETF
Proportion2.25%
ProShares Ultra Nasdaq Biotechnology
Proportion1.62%
Goldman Sachs Future Health Care Equity ETF
Proportion1.44%
Global X Guru Index ETF
Proportion1.36%
Tema Heart & Health ETF
Proportion1.33%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion1.18%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of MDGL?
The top five shareholders of MDGL are:
Baker Bros. Advisors LP holds 2.14M shares, accounting for 9.61% of the total shares.
RTW Investments L.P. holds 1.99M shares, accounting for 8.94% of the total shares.
Paulson & Co. Inc. holds 2.09M shares, accounting for 9.37% of the total shares.
Janus Henderson Investors holds 2.19M shares, accounting for 9.83% of the total shares.
Avoro Capital Advisors LLC holds 1.88M shares, accounting for 8.41% of the total shares.
Baker Bros. Advisors LP holds 2.14M shares, accounting for 9.61% of the total shares.
RTW Investments L.P. holds 1.99M shares, accounting for 8.94% of the total shares.
Paulson & Co. Inc. holds 2.09M shares, accounting for 9.37% of the total shares.
Janus Henderson Investors holds 2.19M shares, accounting for 9.83% of the total shares.
Avoro Capital Advisors LLC holds 1.88M shares, accounting for 8.41% of the total shares.
What are the top three shareholder types of MDGL?
The top three shareholder types of MDGL are:
Baker Bros. Advisors LP
RTW Investments L.P.
Paulson & Co. Inc.
Baker Bros. Advisors LP
RTW Investments L.P.
Paulson & Co. Inc.
How many institutions hold shares of MDGL (MDGL)?
As of 2025Q3, 657 institutions hold shares of MDGL, with a combined market value of approximately 21.99M, accounting for 96.81% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -9.39%.
What is the biggest source of revenue for MDGL?
In --, the -- business generated the highest revenue for MDGL, amounting to -- and accounting for --% of total revenue.
